When telemedicine is discussed, the first thing that usually comes to mind is the remote consultation. In the management of chronic diseases, however, its most significant contribution lies in ensuring continuity of care.

The most advanced digital healthcare models are increasingly moving towards a closed-loop care approach, where remote monitoring becomes an integral part of the clinical pathway. Data generated by the patient must be transformed into documented interventions, structured follow-up, and therapeutic decisions. It should not remain confined within a separate information silo.

This requires overcoming a still fragmented view of telemedicine. The real issue is not how many devices are distributed or how many digital interactions are recorded. What matters is whether remote and in-person care share the same clinical context.

GliConnect® is Meteda’s telemonitoring solution for people with diabetes, developed with this objective in mind: to integrate glycemic data into a clinical workflow that is fully aligned with the electronic medical record, follow-up processes, and therapeutic decision-making.